Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitisMilena Penkowa, Juan Hidalgo, Carmen Espejo et al.|Journal of Neuroimmunology|2001Cited by 74
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based studyTrine Trab, Kirsten Grønbæk, Iman Chanchiri et al.|Blood Neoplasia|2025Cited by 4
Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus VenetoclaxLaura Eurelings, Mark‐David Levin, Henrik Frederiksen et al.|Blood|2024Cited by 1
Secondary central nervous system lymphoma (<scp>SCNSL</scp>) in mantle cell lymphoma (<scp>MCL</scp>): Characteristics and risk factors in a Danish nationwide population‐based studyTrine Trab, Kirsten Grønbæk, Torgerð Ranadóttir et al.|British Journal of Haematology|2025Cited by 0